Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 928 blog entries.

July 2026

CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development

2026-07-27T11:36:19+00:00

Consortium initially brings together Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix and Indica Labs to give biopharma sponsors a single CRO-led, global AI-agnostic path to evaluate and apply digital pathology, image analysis, spatial biology and precision diagnostics capabilities across oncology, autoimmune, neurodegenerative and other disease areas. CellCarta, a leading global CRO laboratory to the [...]

CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development2026-07-27T11:36:19+00:00

Lumito Reports Positive Results from Ongoing Collaborative Research Projects – SCIZYS Demonstrates High Sensitivity Across Multiple Applications

2026-07-27T13:22:01+00:00

Lumito AB today announces positive results from ongoing collaborative projects with external researchers, further strengthening the evidence supporting the Company's tissue analysis platform, SCIZYS. In a pilot project conducted together with Professor Anders Bjartell at Lund University, SCIZYS successfully identified the biomarker PSA in lymph node tissue from prostate cancer. At the same time, research carried [...]

Lumito Reports Positive Results from Ongoing Collaborative Research Projects – SCIZYS Demonstrates High Sensitivity Across Multiple Applications2026-07-27T13:22:01+00:00

Innovators at the Table: Hamamatsu’s Path from Photons to Pathology

2026-07-24T15:03:01+00:00

By Abigail Diepeveen What does a 73-year-old Japanese photonics company have to do with your biopsy results? More than you’d think.In this episode of PathPulse, part of our Behind the Summit series spotlighting the sponsors of the Digital Diagnostic Summit, host Bianca Collings sits down with Stephanie Fullerton, PhD, Director of Life Science Marketing, and Scott M. [...]

Innovators at the Table: Hamamatsu’s Path from Photons to Pathology2026-07-24T15:03:01+00:00

Microtomy and Sectioning at NYU Langone

2026-09-29T13:03:42+00:00

See how NYU Langone’s histotechnologists turn paraffin blocks into tissue sections only a few microns thick. Rui Soares explains the precision, technique and careful contamination controls behind microtomy, before following each delicate section onto a glass slide ready for staining. Explore NYU Langone

Microtomy and Sectioning at NYU Langone2026-09-29T13:03:42+00:00

How We Built Intelligence into the Pathology Platform

2026-07-24T14:44:58+00:00

by Coleman Stavish This post is about Concentriq AP and Concentriq LS, which are for Research Use Only, and the research and laboratory workflows they support. It does not describe diagnostic use. Concentriq AP-Dx, Proscia's product cleared for primary diagnosis, is a separate product and is not covered here. We recently [...]

How We Built Intelligence into the Pathology Platform2026-07-24T14:44:58+00:00

Paraffin Embedding and Blocking at NYU Langone

2026-09-29T13:03:23+00:00

Rui Soares takes us through the transformation of prepared tissue into paraffin blocks ready for sectioning. Explore the science behind tissue processing, the equipment supporting NYU Langone’s high-volume laboratory and the safeguards that maintain specimen identity throughout the workflow Explore NYU Langone

Paraffin Embedding and Blocking at NYU Langone2026-09-29T13:03:23+00:00

AI Flags 250,000 Cancer Studies as Scientists Warn of Fake Research Surge

2026-07-27T11:20:35+00:00

New screening tool identifies studies with signs linked to scientific paper mills Artificial intelligence is now being used to tackle a growing problem in science itself. Researchers have developed an AI tool that sifts through 2.6 million cancer studies published over the past 25 years and flagged more than 250,000 papers for closer scrutiny. The [...]

AI Flags 250,000 Cancer Studies as Scientists Warn of Fake Research Surge2026-07-27T11:20:35+00:00

Tribun Health Supports CGI’s Vendor of Record Selection Across All Four Mohawk Medbuy Digital Pathology Software Categories

2026-07-22T08:12:27+00:00

Tribun Health, a global leader in Digital Pathology solutions, today announced that its strategic partner CGI has been awarded Vendor of Record  (VOR) status across all four software categories in the Mohawk Medbuy Corporation (MMC) Digital Pathology procurement. Through the CGI–Tribun Health partnership, CaloPix® supports a comprehensive Digital Pathology offering spanning workflow, artificial intelligence, image [...]

Tribun Health Supports CGI’s Vendor of Record Selection Across All Four Mohawk Medbuy Digital Pathology Software Categories2026-07-22T08:12:27+00:00

Lumito’s Founder and Board Member Stefan Andersson-Engels Presented at the Prestigious Gordon Research Conference 2026

2026-07-21T16:26:43+00:00

Lumito AB announces today tha Company’s founder and Board member Stefan Andersson-Engels has participated as an invited speaker at the prestigious conference Optics and Photonics in Medicine and Biology Gordon Research Conference (GRC) 2026. During the conference, Stefan Andersson-Engels presented the lecture "Illuminating Biology Across Scales: Upconverting Nanoparticles as Background-Free Contrast Agents for Precision Imaging." The [...]

Lumito’s Founder and Board Member Stefan Andersson-Engels Presented at the Prestigious Gordon Research Conference 20262026-07-21T16:26:43+00:00

New Pan-Cancer Atlas Reveals Two Immune Hubs That Predict Immunotherapy Response

2026-07-20T07:54:42+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor  A recent single-cell analysis by researchers at KU Leuven and the VIB Center for Cancer Biology, spanning nine cancer types, has identified two distinct immune-reactive structures within tumors that predict both early and long-term responses to immune checkpoint blockade therapy. The researchers characterized over 600,000 cells to create a detailed atlas [...]

New Pan-Cancer Atlas Reveals Two Immune Hubs That Predict Immunotherapy Response2026-07-20T07:54:42+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top